» Articles » PMID: 24657130

The 'immunologic Theory' of Preeclampsia Revisited: a Lesson from Donor Oocyte Gestations

Overview
Publisher Elsevier
Date 2014 Mar 25
PMID 24657130
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the prevalence of placental complications in patients conceived through donor versus autologous oocytes.

Study Design: A retrospective cohort study including 2 groups of patients who conceived through in vitro fertilization using: (1) donor oocyte (n = 139) and (2) autologous oocyte (n = 126). Only singleton gestations were included. The rate of placental complications including preeclampsia, gestational hypertension, and intrauterine growth restriction was compared between these 2 groups.

Results: The women who conceived using donor oocytes were older compared with women who conceived using autologous oocytes (median maternal age 45 vs 41, P < .01). The rate of hypertensive diseases of pregnancy including gestational hypertension and preeclampsia was significantly higher in ovum donor recipients compared with women conceived with autologous oocytes (25% vs 10%, P < .01). Similarly, the rate of intrauterine growth restriction was also higher among patients conceived through oocyte donation although it did not reach statistical significance (9.3% vs 4%, P = .08). When maternal age was restricted to ≤45 years, the rate of hypertensive diseases of pregnancy remained significantly higher among ovum donor compared with autologous oocyte recipients (22% vs 10%, P = .02). Adjustment for maternal age, gravidity, parity, and chronic hypertension revealed that oocyte donation was independently associated with higher rate of hypertensive diseases of pregnancy (P = .01).

Conclusion: Patients conceived through oocyte donation have an increased risk for placental complications of pregnancy. These findings support the 'immunologic theory' suggesting that immunologic intolerance between the mother and the fetus may play an important role in the pathogenesis of preeclampsia.

Citing Articles

Development of the DONOR prediction model on the risk of hypertensive complications in oocyte donation pregnancy: study protocol for a multicentre cohort study in the Netherlands.

Lafeber G, Van der Endt V, Louwers Y, le Cessie S, van der Hoorn M, Lashley E BMJ Open. 2024; 14(7):e079394.

PMID: 38960461 PMC: 11227773. DOI: 10.1136/bmjopen-2023-079394.


Comparison of Obstetric Outcomes Between IVF cycles with Donor Oocyte and Spontaneous Conception Pregnancies: A Retrospective Cohort study.

Vikas Y, Neena M, Reeta M, Neeta S, Alka K J Reprod Infertil. 2022; 23(2):100-106.

PMID: 36043129 PMC: 9363908. DOI: 10.18502/jri.v23i2.8994.


Altruistic Donation of Surplus Embryos to Known and Unknown Recipients, The Dutch Approach.

Pieters J, Van Miltenburg M Int J Fertil Steril. 2022; 16(3):230-236.

PMID: 36029062 PMC: 9396005. DOI: 10.22074/ijfs.2022.538120.1183.


Pathological AT1R-B2R Protein Aggregation and Preeclampsia.

Quitterer U, AbdAlla S Cells. 2021; 10(10).

PMID: 34685589 PMC: 8533718. DOI: 10.3390/cells10102609.


Lifting the veil of secrecy: maternal and neonatal outcome of oocyte donation pregnancies in Germany.

Altmann J, Kummer J, Herse F, Hellmeyer L, Schlembach D, Henrich W Arch Gynecol Obstet. 2021; 306(1):59-69.

PMID: 34605992 PMC: 9300520. DOI: 10.1007/s00404-021-06264-8.